GSK Agrees to Settle Flonase Antitrust Actions for $195 Mil.

, The Legal Intelligencer


Drugmaker GlaxoSmithKline has agreed to settle with plaintiffs for a total of $195 million over allegations that it monopolized the market for its nasal spray Flonase.

This premium content is reserved for The Legal Intelligencer subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

  • RD Legal Funding

    This is a great win for the plaintiffs involved. There have been a rash of companies that have settled lawsuits that have to do with these kinds of issues. This seems like a regular settlement in these kinds of situations except there are deeper consequences because of drugs.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202581978415

Thank you!

This article's comments will be reviewed.